Controversies in the management of anti-TNF therapy in patients with Crohn’s disease: a Delphi consensus
Background Despite research, there are still controversial areas in the management of Crohn’s disease (CD).Objective To establish practical recommendations on using anti-tumour necrosis factor (TNF) drugs in patients with moderate-to-severe CD.Methods Clinical controversies in the management of CD u...
Saved in:
Main Authors: | Ignacio Marin-Jimenez, Guillermo Bastida, Daniel Carpio, Fernando Muñoz, Yago González-Lama, Elena Ricart, Daniel Ceballos, Daniel Ginard, Luis Menchen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-01-01
|
Series: | BMJ Open Gastroenterology |
Online Access: | https://bmjopengastro.bmj.com/content/11/1/e001246.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Portuguese consensus on first line treatment of moderate-to-severe psoriasis with a non-TNF inhibitor therapy – a delphi methodology
by: Tiago Torres, et al.
Published: (2025-12-01) -
Vertebrate TNF Superfamily: Evolution and Functional Insights
by: Ignacio Marín
Published: (2025-01-01) -
Intestinal Tuberculosis Masquerading as Crohn’s Disease? A Case of Disseminated Tuberculosis after Anti-TNF Therapy for Suspected Crohn’s Disease
by: Alexander P. Abadir, et al.
Published: (2019-01-01) -
Listeria Rhombencephalitis Complicating Anti-TNF Treatment during an Acute Flare of Crohn’s Colitis
by: L. Stratton, et al.
Published: (2016-01-01) -
Biology of Inflammation in Crohn's Disease: Mechanisms of Action of Anti-TNF-αAlpha Therapy
by: Stephan R Targan
Published: (2000-01-01)